Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-11
2009-10-27
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S159000
Reexamination Certificate
active
07608628
ABSTRACT:
Compounds of Formula IIwherein R1, A, R2, R3, R4, R5, R8, n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
REFERENCES:
patent: 5177096 (1993-01-01), Keenan et al.
patent: 5248689 (1993-09-01), Girard et al.
patent: 5444081 (1995-08-01), Gleason et al.
patent: 5686455 (1997-11-01), Adams et al.
patent: 5811553 (1998-09-01), Farina et al.
patent: 5942523 (1999-08-01), Bichon et al.
patent: 6057362 (2000-05-01), Yamashita
patent: 6232342 (2001-05-01), Carr et al.
patent: 6277862 (2001-08-01), Giardina et al.
patent: 6387898 (2002-05-01), Feuerstein et al.
patent: 6608083 (2003-08-01), Farina et al.
patent: 6743804 (2004-06-01), Giardina et al.
patent: 6858630 (2005-02-01), Luengo et al.
patent: 7253286 (2007-08-01), Funahashi et al.
patent: 2003/0195204 (2003-10-01), Giardina et al.
patent: 2004/0006135 (2004-01-01), Sobolov-Jaynes et al.
patent: 2007/0254886 (2007-11-01), Habashita et al.
patent: 1192952 (2002-04-01), None
patent: 0804419 (2003-08-01), None
patent: 0940391 (2004-08-01), None
patent: 9532948 (1995-12-01), None
patent: 9602509 (1996-02-01), None
patent: 97/19927 (1997-06-01), None
patent: 97/21680 (1997-06-01), None
patent: 9719926 (1997-06-01), None
patent: WO 9719928 (1997-06-01), None
patent: WO 9951565 (1999-10-01), None
patent: WO 0012497 (2000-03-01), None
patent: 0031037 (2000-06-01), None
patent: 0064877 (2000-11-01), None
patent: WO 0213825 (2002-02-01), None
patent: 0238548 (2002-05-01), None
patent: WO 02094187 (2002-11-01), None
patent: 2004000355 (2003-12-01), None
patent: 2004050626 (2004-06-01), None
patent: 2004050627 (2004-06-01), None
patent: WO 2004087153 (2004-10-01), None
patent: WO 2005014532 (2005-02-01), None
patent: WO 2005014533 (2005-02-01), None
patent: WO 2005014534 (2005-02-01), None
patent: WO 2005094801 (2005-10-01), None
patent: WO 2005108359 (2005-11-01), None
patent: 2006/050991 (2006-05-01), None
patent: 2006/120478 (2006-11-01), None
patent: WO 2006/137789 (2006-12-01), None
patent: WO 2007022059 (2007-02-01), None
patent: 2008021388 (2008-02-01), None
Giardina et al.: Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-(N)-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboximide (SB 223412). J Med Chem, 42:1053-1065, 1999.
Wolff, Manfred E.: Burger's Medicinal Chemistry and Drug Discovery, 5ed. Part I. John Wiley & Sons, p. 975-977, 1995.
Banker et al.: Modern Pharmaceutics. 3ed. Marcel Dekker, Inc., New York, p. 451 and p. 596, 1996.
Jeffrey S. Albert, “Neurokinin antagonists and their potential role in treating depression and other stress disorders,” Expert Opin. Ther. Patents, 14(10), pp. 1421-33 (2004).
Jeffrey S. Albert, et. al., “Neurokinin-3 receptor antagonists in schizophrenia”, Expert Opin. Ther. Patents, 16 (7), pp. 925-937 (2006).
Giardina, et al., Discovery of a novel Class of Selective Non-Peptide Antagonists for the Human Neurikinin-3Receptor. 2. Identification of (S)-N-(1-Phenylpropyl)-3-Hydroxy-2-Phenylquinoline-4-Carboxamide (SB 223412), Journal of Med. Chem., 1999, vol. 42, pp. 1053-1065.
Memorandum dated Apr. 6, 2006 regarding US Patent No. 6,608,083 which was filed May 25, 1995.
Albert Jeffrey S.
Alhambra Cristobal
Kang James
Koether Gerald M.
Li Yan
AstraZeneca AB
Baek Bong-Sook
Kwon Brian-Yong S
Mitchell Kenneth F.
LandOfFree
Alkylsulphonamide quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylsulphonamide quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylsulphonamide quinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4060650